Technetium myocardial perfusion agents: an introduction

Journal Article · Tue Sep 01 00:00:00 EDT 1987 · J. Nucl. Med. Technol.; (United States)

OSTI ID:5876814

English, R J; Kozlowski, J; Tumeh, S S; Holman, B L

This is the third in a series of four Continuing Education articles on developing radiopharmaceuticals. After reading this article, the reader should be able to: 1) understand the basic concepts of myocardial perfusion imaging; and 2) discuss the advantages of the technetium myocardial perfusion complexes over thallium-201.

• Research Organization: Brigham and Women's Hospital, Boston, MA
• OSTI ID: 5876814
• Journal Information: J. Nucl. Med. Technol.; (United States), Vol. 15:3
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
MYOCARDIUM
SCINTISCANNING
RADIOPHARMACEUTICALS
CHEMICAL PROPERTIES
GOLD 195
PATIENTS
PERFUSED TISSUES
RADIOISOTOPE GENERATORS
THALLIUM 201
ANIMAL TISSUES
BETA DECAY RADIOISOTOPES
BODY
CARDIOVASCULAR SYSTEM
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
GOLD ISOTOPES
HEART
HEAVY NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MUSCLES
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIOISOTOPE SCANNING
RADIOISOTOPES
SECONDS LIVING RADIOISOTOPES
THALLIUM ISOTOPES
TISSUES
550601* - Medicine- Unsealed Radionuclides in Diagnostics